Rare Disease
Delivering innovative medicines that make a significant difference for patients suffering from serious diseases.
LIVE. WIN. THRIVE.
Every Patient Counts
A rare disease is defined as a disease or condition that affects less than 200,000 people in the United States, according to the FDA. However, one out of every 10 people is living with a rare disease in America alone. At Amgen, our mission to serve patients goes beyond our six core therapeutic areas. We work to serve every patient, every time.
Discover Purpose Through Your Career
At Amgen, your ideas are the first step. We're on a continued goal of transforming biotech to better understand human diseases—and how to fight them. Here's what it takes: The courage to dive into the challenges most won't and never forgetting who relies on our success.
With our combined perspectives, we can build a better world for patients. Join us and discover purpose through your career.
Innovative Medicines
We have a presence in approximately 100 countries and regions worldwide and our innovative medicines have reached millions of people in the fight against serious illnesses. Our medicines typically address diseases for which there are limited treatment options, or they are medicines that provide a viable option to what is otherwise available.
Transformative Research
Understanding the fundamental biological mechanisms of disease is a defining feature of Amgen's discovery research efforts and a major contributor to the development of Amgen's deep and broad pipeline of potential new medicines.
World-Class Biomanufacturing
A worldwide leader in biologics manufacturing, Amgen has an outstanding track record of reliably delivering high-quality medicines to patients who need them. At Amgen, robust quality control and a reliable supply of medicines for patients are every bit as important as scientific innovation.
Learn About the Rare Disease Community
Watch as Leigh-Ana shares her goals of uniting those in need through science as part of our #RAREis program dedicated to elevating the voices, faces and experiences of the rare disease community.
Watch Video
